Serum lipids and lipoproteins in schizophrenic patients with normal renal function treated with hemodialysis.
To study the effect of hemodialysis on serum lipids and lipoproteins, five patients with normal renal function who had undergone hemodialysis for schizophrenic symptoms for 10 weeks in a crossover study were investigated. Active or sham (no dialysate flow through the filter) dialysis was instituted randomly. Serum lipids were isolated by ultracentrifugation and precipitation before and after each period. High density lipoprotein (HDL) cholesterol levels were constantly low and correlated negatively with serum alkaline phosphatase concentrations (p less than 0.05). Serum and very low density lipoprotein (VLDL) triglycerides and VLDL cholesterol increased during active, and to a lesser extent during sham, dialysis. Dialysis of this intensity does not affect HDL. The low levels may be secondary to subclinical cholestasis from neuroleptic drug treatment. Some individuals may develop hypertriglyceridemia of unknown pathogenesis during hemodialysis. Both these lipoprotein abnormalities are risk factors for the development of atherosclerosis.
D000328:Adult; D001161:Arteriosclerosis / Q000209:etiology; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL; D015243:Cholesterol, VLDL; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D011897:Random Allocation; D006435:Renal Dialysis; D012306:Risk; D012559:Schizophrenia / Q000097:blood / Q000628:therapy*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014461:Ultracentrifugation
D008076:Cholesterol, HDL; D015243:Cholesterol, VLDL; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; C030106:very low density lipoprotein triglyceride; D002784:Cholesterol